BiotechTube
Home/Noetik/Daniel Bear, PhD
DB

Daniel Bear, PhD

Vice President, AI Research

Noetik

Therapeutic Areas

OncologyImmuno-oncology

Noetik Pipeline

DrugIndicationPhase
AI-Enriched Clinical TrialsOncologyDevelopment
Clinical-Stage Drug RepositioningOncologyPre-clinical/Development
Novel Target DiscoveryCancer ImmunotherapyDiscovery

Leadership Team at Noetik

RW
Ron W. Alfa, MD, PhD
Co-Founder, CEO
LP
Lacey Padrón, PhD
Chief Technology Officer
SV
Shafique Virani, MD, FRCS
Chief Business Officer
EC
Emily Corse, PhD
Executive Vice President, Therapeutics
View full Noetik profile